HMGB1 inhibitors/antagonists (Bio3)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHMGB1 inhibitors/antagonists (Bio3)
Drug Alias NameFRAG AHMGB1 inhibitors/antagonists (Bio3)CT-406
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHigh Mobility Group Protein B1 inhibitors
TargetsHigh Mobility Group Protein B1
Therapy Area/IndicationsCardiovascular DiseasesMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCreabilis Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBio3 ResearchCreabilis Sa
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A